Theranova was designed to deliver expanded hemodialysis (HDx) therapy, which filters a wider range of molecules from the blood than traditional hemodialysis (HD) filters, like high-flux membranes, by targeting effective removal of conventional (500 Da to 25 kDa) and large middle molecules (25 kDa to 45 kDa)
As part of the agreement, Baxter will support clinical studies required to achieve regulatory approval in key markets worldwide and gain global distribution rights. Additional terms of the agreement were not disclosed.
Peri-Strips Dry With Secure Grip Technology for Reliable Staple Line Reinforcement in Surgical Procedures Launched
Now available with “peel and secure” technology, PSDV is a staple line reinforcement material that bariatric surgeons have used to mitigate staple line complications for more than 15 years. This new generation of PSDV is two times faster to prepare compared to the previous version and another staple line reinforcement product.
The agreement provides that Baxter will bring Q-NRG+ to 18 key countries around the world with potential for further expansion. Q-NRG+ is expected to be available from Baxter in September as part of a phased launch in select European countries, Canada and Australia, with launches in additional markets pending future regulatory approval. Additional terms of the agreement were not disclosed.
“While the global patient population requiring dialysis is growing, the number of clinicians and their resources are not increasing,” says Laura Angelini, general manager, of Baxter Renal Care business.
Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury
3/19/19: The announcement was made at the International Symposium on Intensive Care and Emergency Medicine this week.
2/11/19: “The ICU requires coordinated care among specialists and nurses, further complicated by the need to manage data streams from numerous medical devices,” said Brian Tufts, Baxter’s lead for Acute Therapies in the U.S. “When customers use technology to streamline connectivity of Prismaflex to their IT systems, busy nurses are no longer tasked with manually charting treatment data. We are excited about this development as we work to create digital health solutions to help our customers turn data into meaningful insights to improve patient care.”
Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management
1/17/19: Baxter’s Sharesource remote patient management platform has logged more than 5 million home peritoneal dialysis treatments globally; milestone is evidence that smarter, more effective innovation is enhancing renal care.
12Page 1 of 2